🔎 Trials Near Me

Beranda › Dermatitis Atopik (Eksim) › Nevada

Uji klinis Dermatitis Atopik (Eksim) di Nevada

6 studi untuk Dermatitis Atopik (Eksim) mencari peserta di lokasi di Nevada.

Kota di Nevada

Teks studi resmi (Bahasa Inggris)

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

  • Las Vegas Dermatology- Site Number : 8400002, Las Vegas
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07290803

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

  • Enveda Investigative Site, Las Vegas
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07298395

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

  • Advanced Dermatology and Cosmetic Surgery - Henderson, Henderson
  • Las Vegas Dermatology, Las Vegas
Menerima pesertaStudi observasional
Usia 12 hingga 89 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07645820

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • Skin Cancer and Dermatology Institute, Reno
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07599813

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

  • Las Vegas Dermatology /ID# 265801, Las Vegas
  • Skin Cancer And Dermatology Institute (Scdi) - Reno /ID# 263771, Reno
Menerima pesertaFase 3
Usia 18 hingga 63 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06389136

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

  • Galderma Investigational Site 8848, Las Vegas
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT06988605

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.